S 3077
114th Congress
Senate
Crime and Law Enforcement
Administrative law and regulatory procedures
Alternative treatments
Drug safety, medical device, and laboratory regulation
Drug therapy
Drug trafficking and controlled substances
Health personnel
Licensing and registrations
Medical research
Research administration and funding
MEDS Act
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 20, 2016
Read twice and referred to the Committee on the Judiciary.
Jun 20, 2016
Introduced in Senate
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Marijuana Effective Drug Studies Act of 2016 or the MEDS Act
This bill amends the Controlled Substances Act to:
- establish, with respect to marijuana research, a new federal registration process that is separate from the process for research involving other schedule I drugs;
- establish a process for registering persons to manufacture or distribute marijuana for purposes of either research or the commercial production of certain approved drugs containing or derived from marijuana; and
- modify other requirements related to marijuana research and production.
What's happening now
Read twice and referred to the Committee on the Judiciary.
Bill text
1 version
- Introduced in Senate Formatted Text PDF Formatted XML
Committees of jurisdiction
1
Cosponsors
2
Cite this page
U.S. Congress. (2026). S. 3077: MEDS Act. 114th Congress. Open America. https://openamerica.io/bill/114-S-3077/
"S. 3077: MEDS Act." 114th Congress, 2026, Open America, https://openamerica.io/bill/114-S-3077/.
S. 3077, 114th Cong. (2026), https://openamerica.io/bill/114-S-3077/.
[S. 3077: MEDS Act](https://openamerica.io/bill/114-S-3077/)